Gynecologic Pathology - Mayo Clinic Laboratories
In gynecologic pathology, we see a wide variety of cases from ovarian tumors, and endometrial lesions to gestational disease problems
Renal Pathology at Mayo Clinic
The renal pathology section at Mayo Clinic Laboratories examines kidney biopsy specimens by light microscopy, immunofluorescence, electron microscopy, and ancillary techniques to provide the most thorough evaluation.
Endocrine Pathology Service at Mayo Clinic Laboratories
Our endocrine pathology section is highly specialized and provides a valuable consultative service that is hard to find elsewhere.
Neuropathogy at Mayo Clinic Laboratories
Learn more about neuropathology at Mayo Clinic Laboratories, which provides expert second options across the spectrum of neurological disease.
New Tests Launched in May - Insights
In May 2017, Mayo Medical Laboratories announced eight brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
TPMT Testing in Treatment of Inflammatory Bowel Disease [Test in Focus] - Insights
Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Mayo Clinic's Discovery's Edge Highlights How New Tests Are Developed - Insights
Discovery's Edge, Mayo Clinic's research magazine, recently highlighted how new tests are developed in Mayo Clinic’s Neuroimmunology Laboratory.
New Blood Test to Help Determine Heart Disease Highlighted in European Heart Journal - Insights
European Heart Journal recently highlighted Mayo Clinic's new blood test that may predict cardiovascular events in patients with or without coronary artery disease.
New Tests Launched in March - Insights
In March 2018, Mayo Medical Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in October - Insights
In October 2017, Mayo Medical Laboratories announced eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Sarcoma Testing - Mayo Clinic Laboratories
Supplementing the histologic diagnosis with genetic testing can improve diagnostic accuracy and overall patient management.
Lung Cancer PDL1 Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers three PD-L1 clones for assessing patient response to specific therapies.
Single Gene Sarcoma Testing - Mayo Clinic Laboratories
In cases where comprehensive NGS analysis cannot be performed or the diagnosis is highly suspect, we also offer a variety of single-gene fluorescence in situ hybridization (FISH) tests
See how our unique panel includes testing for antibodies proven to be associated with paraneoplastic or cancer-associated retinopathy.
Ethical Issues in Phlebotomy - Insights
This "Phlebotomy webinar" will discuss ethical issues frequently faced by phlebotomists.
Find out how our sarcoma panel assesses gene mutations and fusions described in more than 50 types of soft tissue, bone, and other mesenchymal tumors.
Ganglioside-associated neuropathies - Insights
Learn how Mayo Clinic Laboratories’ ganglioside antibody evaluation can provide diagnostic clarity and a path forward for patients impacted by autoimmune peripheral neuropathy.
Comprehensive inherited neuropathy panel - Insights
Learn how our comprehensive inherited neuropathy panel simplifies the diagnostic process by evaluating 186 genes with associations to inherited neuropathy.
Mayo Clinic Laboratory and pathology research roundup: June 20 - Insights
This week's research roundup feature: Career decisions, training priorities, and perceived challenges for anesthesiology residents in the United States.
Mayo Clinic Laboratory and pathology research roundup: May 2 - Insights
This week's Research Roundup feature: Head-to-head comparison of MR elastography-based liver stiffness, fat Fraction, and T1 relaxation time in identifying at-risk NASH.
COVID-19 weekly news: March 21-27 2022 - Insights
Topic's Include: Breakthrough hospitalizations ‘extremely uncommon’ after COVID-19 immunity, Mayo study finds, and Mayo Clinic in Rochester continues to ease visitor restrictions for hospitalized patients.
New communication process for CPT Code changes - Insights
Mayo Clinic Laboratories (MCL) is pleased to announce an essential update to our CPT code communication process and website layout. This change is designed to bring timely notifications for accurate billing information.
Thanksgiving specimen shipment alert - Insights
Due to the Thanksgiving holiday (recognized on Thursday, November 24th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan...
Holiday specimen shipment - Insights
Due to the holiday season, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan ahead.
Holiday specimen shipment - Insights
Due to the Thanksgiving Day holiday (recognized on Thursday, November 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please...
New tests launched in August - Insights
In August 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Hurricane Idalia: Operations update - Insights
Hurricane Idalia is expected to impact Florida on Wednesday, Aug. 30. We are monitoring and tracking the situation with our logistics partners to minimize challenges.
Optional MFA for Mayo Clinic Laboratories applications coming soon - Insights
Mayo Clinic Laboratories is committed to security and to protecting your information. As part of this commitment, we will implement an optional two-step login process for Mayo Clinic Laboratories applications called Multi-Factor...
Mary Jo Williamson talks resiliency and agility on Fierce Healthcare podcast - Insights
Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, joins the “Fierce Healthcare” podcast to discuss how organizations can cultivate resiliency and agility amidst a changing healthcare landscape.
Domestic Logistics Impacts: Independence Day Holiday Weekend - Insights
Due to the upcoming Independence Day holiday on Tuesday, July 4, Mayo Clinic Laboratories' sample pickup and delivery schedules will be altered. To ensure sample viability and minimize test turnaround time delays, we have implemented...
Memorial Day Specimen Shipment Alert - Insights
Due to the Memorial Day holiday (recognized on Monday, May 29), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan...
In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Week in Review: March 31 - Insights
Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.
New tests launched in February - Insights
In February 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Dr. William Morice provides insights on the evolving technologies in medicine - Insights
In a Fierce Healthcare article, Dr. William Morice highlights AI, digital pathology, and mass spectrometry as key advancements revolutionizing healthcare diagnostics and treatment.
Week in Review: March 17 - Insights
Today's Highlights Include: Rochester public schools receives grant to support youth mental health, and FDA releases new regs intended to help detect breast cancer sooner.
Dr. Matt Binnicker sheds light on new Arcturus COVID-19 variant - Insights
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”
Dr. Leslie Donato discusses lipid testing on ADLM's Laborastories: The Podcast - Insights
Dr. Leslie Donato recently joined “Laborastories: The Podcast,” hosted by the Association for Diagnostics & Laboratory Medicine (ADLM) president Dr. Anthony Killeen, to discuss the publication of the new ADLM lipid and lipoprotein testing...
Establishing a trusted lab partner in an evolving landscape - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support...
Updated authentication for Mayo Clinic Laboratories - Insights
On Saturday, March 13 at 6 p.m. CT, Mayo Clinic Laboratories will be migrating to the authentication service used across Mayo Clinic.
William Morice II, M.D., Ph.D., considers the future of diagnostics - Insights
Dr. Morice talks about what lies ahead for laboratory medicine and how the opportunities and challenges in the field are intertwined.
Hematology journal lauds HIT testing research - Insights
A study involving Mayo Clinic investigators that examined new approaches to the diagnosis of heparin-induced thrombocytopenia has been met with enthusiasm in the scientific community.
Thanksgiving specimen shipment alert - Insights
Due to the Thanksgiving holiday (recognized on Thursday, November 25), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan...
Week in Review: April 7 - Insights
Top highlights include: Government to launch $300M Azlheimer's research database, new COVID variant XBB.1.16 spotted in 18 US states, and novel treatment shows promise against rare cancer in kids.
Monitoring Tropical Storm Francine - Insights
Tropical Storm Francine is active in the Gulf of Mexico and is expected to develop into a hurricane. These weather conditions may impact areas in the United States, including Alabama, Arkansas, Louisiana, Mississippi, Tennessee, and Texas....
How lab innovation drives revenue and accelerates growth - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, recently shared with the Advisory Board his insight into the potential that digital pathology and out-of-lab testing can bring into the...
In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with career educator, Elissa Hall, Ed.D., on the integration and impact of artificial intelligence in graduate medical education, exploring strategies for teaching AI, the...
Attending Medical Conferences & AABB Debrief - Insights
In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., interviews John Sherbeck, M.D., Laboratory Medical Director of Trinity Health IHA Medical Group, about how to plan your time at medical conferences and briefly discusses this...
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Paul Jannetto, Ph.D., associate professor of laboratory medicine and pathology at Mayo Clinic, and discusses how CBD can affect your health, what the medical...
Myasthenia Gravis: The Role of Apheresis - Insights
In this month’s episode of Lab Medicine Rounds, Justin Kreuter, M.D., interviews Jeffrey Winters, M.D., the medical director of the Therapeutic Apheresis Treatment Unit at Mayo Clinic for Myasthenia Gravis Awareness Month.